TGFβ1 and sCTLA-4 levels are increased in eltrombopag-exposed patients with ITP

Thrombosis Research

Volumn 130, Issue 3, 2012, Pages 415-419

  Fujita, Shinya ^a   Nakanishi, Takahisa ^a   Yoshimura, Hideaki ^a   Hotta, Masaaki ^a   Nakamichi, Naoto ^a   Tamaki, Takeshi ^a   Ishii, Kazuyoshi ^a   Ito, Tomoki ^a   Nomura, Shosaku ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Eltrombopag; Immune tolerance; ITP; sCTLA 4; TGF 1

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; ELTROMBOPAG; GLYCOPROTEIN; GLYCOPROTEIN ANTIBODY; SOLUBLE CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHEMICAL ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE INCREASE; FEMALE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THROMBOCYTE COUNT;

BENZOATES; CTLA-4 ANTIGEN; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; HYDRAZINES; MALE; MIDDLE AGED; PURPURA, THROMBOCYTOPENIC; PYRAZOLES; RECEPTORS, THROMBOPOIETIN; TRANSFORMING GROWTH FACTOR BETA1; TREATMENT OUTCOME;

EID: 84865215613     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2012.06.002     Document Type: Article

References (34)

1. D.B. Cines, and V.S. Blanchette Immune thrombocytopenic purpura N Engl J Med 346 2002 995 1008
2. J.W. Semple, Y. Milev, D. Cosgrave, M. Mody, A. Hornstein, and V. Blanchette Differences in serum cytokines levels in acute and chronic autoimmune thrombocytopenic purpura: relationhip to platelet phenotype and antiplatelet T-cell reactivity Blood 87 1996 4245 4254
3. M. Kuwana, J. Kaburaki, and Y. Ikeda Autoreactive T cells to platelet GPIIb-IIIa in immune thrombocytopenic purpura: role in production of antiplatelet autoantibody J Clin Invest 102 1998 1393 1402
4. S. Nomura, T. Matsuzaki, Y. Ozaki, M. Yamaoka, C. Yoshimura, and K. Katsura Clincal significance of HLA-DRB1*0410 in Japanese patients with idiopathic thrombocytopenic purpura Blood 91 1998 3616 3622
5. M. Kuwana, J. Kaburaki, H. Kitasato, M. Kato, S. Kawai, and Y. Kawakami Immunodominant epitopes on glycoprotein IIb-IIIa recognized by autoreactive T cells in patients with immune thrombocytopenic purpura Blood 98 2001 130 139
6. P. Miossec, T. Korn, and V.K. Kuchroo Mechanisms of desease: Interleukin-17 and type 17 helper T cells N Engl J Med 361 2009 888 898
7. F.P. Panitsas, M. Theodoropoulou, A. Kouraklis, M. Karakantza, G.L. Theodorou, and N.C. Zoumbos Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type-1 polarized immune response Blood 103 2004 2645 2647
8. T.T. Wang, H. Zhao, H. Ren, J. Guo, M. Xu, and R. Yang Type 1 and type 2 T-cell profiles in idiopathic thrombocytopenic purpura Haematologica 90 2005 914 923
9. J.D. Wang, T.K. Chang, H.K. Lin, F.L. Huang, C.J. Wang, and H.J. Lee Reduced expression of transforming growth factor-β1 and correlated elevation of interleukin-17 and interferon-γ in pediatric patients with chronic primary immune thrombocytopenia (ITP) Pediatr Blood Cancer 57 2011 636 640
10. X.L. Zhang, J. Peng, J.Z. Sun, J.J. Liu, C.S. Guo, and Z.G. Wang De novo induction of platelet-specific CD4+CD25+ regulatory T cells from CD4+CD25- cells in patients with idiopathic thrombocytopenic purpura Blood 113 2009 2568 2577
11. W. Bao, J.B. Bussel, S. Heck, W. He, M. Karpoff, and N. Boulad Improved regulatory T-cell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agents Blood 116 2010 4639 4645
12. S. Sakaguchi Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses Annu Rev Immunol 22 2004 531 562
13. H. Von Boehmer Mechanisms of suppression by suppressor T cells Nat Immunol 6 2005 338 344
14. J. Yu, S. Heck, V. Patel, J. Levan, Y. Yu, and J.B. Bussel Defective circulating CD25 regulatory T cells in patients with chronic immune thrombocytopenic purpura Blood 112 2008 1325 1328
15. + regulatory T cells in adult patients with chronic ITP before and after treatment with high-dose dexamethasone Eur J Haematol 79 2007 310 316
16. B. Liu, H. Zhao, M.C. Poon, Z. Han, D. Gu, and M. Xu Abnormality of CD4(+)CD25(+) regulatory T cells in idiopathic thrombocytopenic purpura Eur J Haematol 78 2007 139 143
17. B. Psaila, and J.B. Bussel Refractory immune thrombocytopenic purpura: current strategies for investigation and management Br J Haematol 143 2008 16 26
18. D.J. Kuter New thrombopoietic growth factors Blood 109 2007 4607 4616
19. M.K. Oaks, and K.M. Hallett A soluble form of CTLA-4 in patients with autoimmune thyroid disease J Immunol 164 2000 5015 5018
20. M.F. Liu, C.R. Wang, P.C. Chen, and L.L. Fung Increased expression of soluble cytotoxic T-lymphocyte-associated antigen-4 molecules in patients with systemic lupus erythematosus Scand J Immunol 57 2003 568 572
21. D.B. Cines, and J.B. Bussel How I treat idiopathic thromnocytopenic purpura (ITP) Blood 106 2005 2244 2251
22. J.B. Bussel, D. Provan, T. Shamsi, G. Cheng, B. Psaila, and L. Kovaleva Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomized, double-blind, placebo- controlled trial Lancet 373 2009 641 648
23. J.B. Bussel, G. Cheng, M.N. Saleh, B. Psala, L. Kovaleva, and B. Meddeb Eltrombopag, an oral platelet growth factor, for the treatment of patients with chronic idiopathic thrombocytopenic purpura N Engl J Med 357 2007 2237 2247
24. A. Mouzaki, M. Theodoropoulou, I. Gianakopoulos, V. Vlaha, M.C. Kyrtsonis, and A. Maniatis Expression patterns of Th1 and Th2 cytokine genes inchildhood idiopathic thrombocytopenic purpura (ITP) at presentation and their modulation by intravenous immunoglobulin G (IVIg) treatment: their role in prognosis Blood 100 2002 1774 1779
25. C. Guo, X. Chu, Y. Shi, W. He, L. Li, and L. Wang Correlation of Th1-dominant cytokine profiles by high-dose dexamethasone in patients with chronic idiopathic thrombocytopenic purpura J Clin Immunol 27 2007 557 562
26. D. Cross, and J.C. Cambier Transforming growth factor beta 1 has differential effects on B cell proliferation and activation antigen expression J Immunol 144 1990 432 439
27. F. Bridoux, A. Badou, A. Saoudi, I. Bernard, E. Druet, and R. Pasquier Transforming growth factor beta (TGF-beta)-dependent inhibition of T helper cell 2 (Th2)-induced autoimmunity by self-major histocompatibility complex (MHC) class II-specific, regulatory CD4(+) T cell lines J Exp Med 185 1997 1769 1775
28. Y.Y. Wan, and R.A. Flawell 'Yin-Yang' functions of transforming growth factor-beta and regulatory cells in immune regulation Immunol Rev 220 2007 199 213
29. A. Kosmaczewska, L. Ciszak, D. Bocko, and I. Frydecka Expression and functional significance of CTLA-4, a negative regulator of T-cell activation Arch Immunol Ther Exp 49 2001 39 46
30. D. Saverino, R. Brizzolara, R. Simone, A. Chiappori, F. Milintenda-Floriani, and G. Pesce Soluble CTLA-4 in autoimmune thyroid diseases: relationship with clinical status and possible role in the immune response dysregulation Clin Immunol 123 2007 190 198
31. E. Pawlak, I.E. Kochanowska, I. Frydecka, M. Kielbinski, S. Potoczek, and M. Bilinska The soluble CTLA-4 receptor: a new marker in autoimmune disease Arch Immunol Ther Exp 53 2005 336 341
32. Q. Tang, E.K. Boden, K.J. Henriksen, H. Bour-Jordan, M. Bi, and J.A. Bluestone Distinct roles of CTLA-4 and TGF-beta in CD4+CD25+ regulatory T cell function Eur J Immunol 34 2004 2996 3005
33. S. Sato, M. Fujimoto, M. Hasegawa, K. Komura, K. Yanaba, and I. Hayakawa Serum soluble CTLA-4 levelss are increased in diffuse cutaneous systemic sclerosis Rheumatology 43 2004 1261 1266
34. D. Saverino, R. Brizzolara, R. Simone, A. Chiappori, F. Milintenda-Floriani, and G. Pesce Soluble CTLA-4 in autoimmune thyroid diseases: relathionship with clinical status and possible role in the immune response dysregulation Clin Immunol 123 2007 190 198